BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28694132)

  • 1. Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population-Based Study.
    Bojesen RD; Riis LB; Høgdall E; Nielsen OH; Jess T
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1900-1907.e2. PubMed ID: 28694132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden.
    Axelrad JE; Olén O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Gut; 2021 Feb; 70(2):297-308. PubMed ID: 32474410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994-2010: a population-based study.
    Bojesen RD; Andersson M; Riis LB; Nielsen OH; Jess T
    J Gastroenterol; 2016 Sep; 51(9):891-9. PubMed ID: 26847562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel.
    Yu J; Refsum E; Perrin V; Helsingen LM; Wieszczy P; Løberg M; Bretthauer M; Adami HO; Ye W; Blom J; Kalager M
    Ann Oncol; 2022 Jun; 33(6):649-656. PubMed ID: 35276334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
    Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality.
    Caspersen S; Elkjaer M; Riis L; Pedersen N; Mortensen C; Jess T; Sarto P; Hansen TS; Wewer V; Bendtsen F; Moesgaard F; Munkholm P;
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1212-7; quiz 1176. PubMed ID: 18848503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk in patients with inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Kliewer E; Wajda A
    Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.
    Kappelman MD; Farkas DK; Long MD; Erichsen R; Sandler RS; Sørensen HT; Baron JA
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):265-73.e1. PubMed ID: 23602821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of malignancy in a high-incidence population-based cohort of Faroese patients with inflammatory bowel disease from 1960 to 2020 - a Faroese IBD cohort study.
    Midjord J; Nielsen KR; Vang AG; Strøm M; Lophaven S; Hammer T; Burisch J
    Scand J Gastroenterol; 2024 Jun; 59(6):661-668. PubMed ID: 38407208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
    J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.
    Herrinton LJ; Liu L; Levin TR; Allison JE; Lewis JD; Velayos F
    Gastroenterology; 2012 Aug; 143(2):382-9. PubMed ID: 22609382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.
    Jess T; Horváth-Puhó E; Fallingborg J; Rasmussen HH; Jacobsen BA
    Am J Gastroenterol; 2013 Dec; 108(12):1869-76. PubMed ID: 23978954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
    Rungoe C; Simonsen J; Riis L; Frisch M; Langholz E; Jess T
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer in inflammatory bowel disease.
    Greenstein AJ
    Mt Sinai J Med; 2000 May; 67(3):227-40. PubMed ID: 10828908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.